Press Releases

Press Releases

April 27, 2018
Establishment Labs Announces Motiva® Implants IDE Clinical Trial Underway with First Patient Enrolled and Surgery Completed
NEW YORK, April 27, 2018 (GLOBE NEWSWIRE) Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies, today announced the enrollment and successful completion of implant surgery on the first patient in its U.S.
March 22, 2018
Establishment Labs Receives IDE Approval from U.S. FDA to Initiate Clinical Trial of Motiva Implants
NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development and innovation, announced today that it has received an investigational device
January 8, 2018
Establishment Labs Appoints Dennis Condon to the Board of Directors
NEW YORK, Jan. 8, 2018 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development and innovation, announced today that Dennis Condon has been appointed to the Board of Directors. Mr.
Displaying 11 - 13 of 13